RETICULOENDOTHELIAL System GL D 8 ampoules

Pack size:10 x 1 ml Dosage form:ampoules

Reticuloendothelial System Gl D8, liquid dilution for injection. Active ingredient: Reticuloendothelial System bovis Gl. Indications: Registered homeopathic medicinal product of the anthroposophical therapeutic approach, therefore no therapeutic indication is specified.

For risks and side effects, read the package insert and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Reticuloendothelial System Gl D8, liquid dilution for injection
. Active ingredient: Reticuloendothelial System bovis Gl.

Composition:
1 ampoule contains: Reticuloendothelial System bovis Gl Dil. D8 1 ml (HAB, Vs. 41a).

Indications:
Registered homeopathic medicinal product of the anthroposophical therapeutic approach, therefore no therapeutic indication is specified.

Contraindications:

• Liquid dilution for injection D4, D5, D6: This medicine should not be used in case of hypersensitivity to the donor animal protein.
• Liquid dilution for injection from D8: None known.

Precautions for use and warnings:
There is no adequately documented experience with the use of this medicine in children. It should therefore not be used in children under 12 years of age.

Dosage and method of administration:
As directed by a doctor.

Duration of use:
Treatment of an acute illness should be completed after 2 weeks. The duration of treatment of chronic illnesses requires consultation with a doctor.

Side effects:
None known.

Contents:
10 x 1 ml.

Pharmaceutical company and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1,
73087 Bad Boll/Eckwälden.

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalog,
as of: 05/2025

Active ingredient: Reticuloendothelial system bovis Gl. Indications: Registered homeopathic medicinal product of the anthroposophical therapeutic approach, therefore without specification of a therapeutic indication.